{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:55:12Z","timestamp":1781650512239,"version":"3.54.5"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T00:00:00Z","timestamp":1776470400000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Ulm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Fatigue and cognitive impairment are common in multiple sclerosis (MS) affecting up to 95% and 65% of the patients, respectively. Only little is known about the interplay of different volumetric magnetic resonance imaging (MRI) parameters, the serum biomarkers neurofilament light chain (sNfL) and glial fibrillary acidic protein (sGFAP), cognition, and fatigue in MS patients without signs of progression independent of relapse activity (PIRA; i.e. clinically stable). This study aimed to evaluate whether volumetric MRI and serum NfL and GFAP are associated with cognitive impairment and fatigue in clinically stable relapsing-remitting multiple sclerosis (RRMS) and to examine whether the Expanded Disability Status Scale (EDSS) has an added value.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective mono-centric cohort of 54 clinically stable (no disability worsening\/relapse-free) RRMS patients underwent comprehensive clinical assessment with the EDSS, Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS-M), Fatigue Scale for Motor and Cognitive Functions (FSMC), in addition to established biomarkers of MS pathology, including sNfL, sGFAP, and magnetic resonance imaging (MRI: thalamic\/hippocampal\/whole brain parenchymal volumes\/annualized brain volume loss (BVL\/year)). Associations were examined using regressions, correlations, and group comparisons.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Thalamic and hippocampal volumes were significantly lower in cognitively impaired than non-impaired patients (both\n                      <jats:italic>p<\/jats:italic>\n                      &lt;.001), while sNfL and sGFAP showed no group differences (\n                      <jats:italic>p<\/jats:italic>\n                      &gt;.35;\n                      <jats:italic>p<\/jats:italic>\n                      &gt;.09). Fatigue was not associated with MRI or serum markers (\n                      <jats:italic>p<\/jats:italic>\n                      &gt;.09). BICAMS-M correlated with EDSS (\n                      <jats:italic>r<\/jats:italic>\n                      =\u2013.56;\n                      <jats:italic>p<\/jats:italic>\n                      &lt;.001) to a similar extent as with thalamic or hippocampal volumes (\n                      <jats:italic>r<\/jats:italic>\n                      =.55;\n                      <jats:italic>p<\/jats:italic>\n                      &lt;.001). BVL\/year was highly associated with cognitive impairment, explaining 63.2% (BICAMS-M) of the variance (\n                      <jats:italic>p<\/jats:italic>\n                      &lt;.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In our clinically stable, small RRMS cohort, BVL\/year, thalamic and hippocampal volumes are associated with cognition in contrast to sNfL and sGFAP. EDSS as a global disability score correlates with cognition but adds little beyond MRI. These results require further validation using a prospective design and broader cohort.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12883-026-04894-6","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T11:37:49Z","timestamp":1776425869000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cognition and fatigue in clinically stable multiple sclerosis: EDSS and MRI metrics outperform serum biomarkers"],"prefix":"10.1186","volume":"26","author":[{"given":"Deborah K.","family":"Erhart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa T.","family":"Balz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Opfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lothar","family":"Spies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska","family":"Bachhuber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Vardakas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Taranu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Fangerau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makbule","family":"Senel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kornelia","family":"Kreiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingo","family":"Uttner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doroth\u00e9e","family":"Lul\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayrettin","family":"Tumani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,17]]},"reference":[{"issue":"10","key":"4894_CR1","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/s1474-4422(20)30277-5","volume":"19","author":"RHB Benedict","year":"2020","unstructured":"Benedict RHB, Amato MP, DeLuca J, Geurts JJG. Cognitive impairment in multiple sclerosis: clinical management, MRI, and therapeutic avenues. Lancet Neurol. 2020;19(10):860\u2013. https:\/\/doi.org\/10.1016\/s1474-4422(20)30277-5. \u200971.","journal-title":"Lancet Neurol"},{"issue":"8","key":"4894_CR2","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1177\/1352458517694432","volume":"23","author":"G Kobelt","year":"2017","unstructured":"Kobelt G, Thompson A, Berg J, Gannedahl M, Eriksson J. New insights into the burden and costs of multiple sclerosis in Europe. Mult Scler. 2017;23(8):1123\u201336. https:\/\/doi.org\/10.1177\/1352458517694432.","journal-title":"Mult Scler"},{"issue":"11","key":"4894_CR3","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1212\/wnl.33.11.1444","volume":"33","author":"JF Kurtzke","year":"1983","unstructured":"Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983;33(11):1444\u201352. https:\/\/doi.org\/10.1212\/wnl.33.11.1444.","journal-title":"Neurology"},{"issue":"1","key":"4894_CR4","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3174\/ajnr.A4952","volume":"38","author":"D Damjanovic","year":"2017","unstructured":"Damjanovic D, Valsasina P, Rocca MA, Stromillo ML, Gallo A, Enzinger C, et al. Hippocampal and Deep Gray Matter Nuclei Atrophy Is Relevant for Explaining Cognitive Impairment in MS: A Multicenter Study. AJNR Am J Neuroradiol. 2017;38(1):18\u201324. https:\/\/doi.org\/10.3174\/ajnr.A4952.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"11","key":"4894_CR5","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s00415-025-13343-2","volume":"272","author":"R Opfer","year":"2025","unstructured":"Opfer R, Spies L, Kr\u00fcger J, Buddenkotte T, Roick H, Jankovic M, et al. Whole brain volume loss is associated with a short-term disability progression in relapse-activity free multiple sclerosis. J Neurol. 2025;272(11):715. https:\/\/doi.org\/10.1007\/s00415-025-13343-2.","journal-title":"J Neurol"},{"issue":"3","key":"4894_CR6","doi-asserted-by":"publisher","first-page":"e0299634","DOI":"10.1371\/journal.pone.0299634","volume":"19","author":"A Kampaite","year":"2024","unstructured":"Kampaite A, Gustafsson R, York EN, Foley P, MacDougall NJJ, Bastin ME, et al. Brain connectivity changes underlying depression and fatigue in relapsing-remitting multiple sclerosis: A systematic review. PLoS ONE. 2024;19(3):e0299634. https:\/\/doi.org\/10.1371\/journal.pone.0299634.","journal-title":"PLoS ONE"},{"key":"4894_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/s1474-4422(25)00249-2","author":"T Chitnis","year":"2025","unstructured":"Chitnis T, Magliozzi R, Abdelhak A, Kuhle J, Leppert D, Bielekova B. Blood and CSF biomarkers for multiple sclerosis: emerging clinical applications. Lancet Neurol. 2025. https:\/\/doi.org\/10.1016\/s1474-4422(25)00249-2.","journal-title":"Lancet Neurol"},{"issue":"2","key":"4894_CR8","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1177\/13524585221137697","volume":"29","author":"C Barro","year":"2023","unstructured":"Barro C, Healy BC, Saxena S, Glanz BI, Paul A, Polgar-Turcsanyi M, et al. Serum NfL but not GFAP predicts cognitive decline in active progressive multiple sclerosis patients. Mult Scler. 2023;29(2):206\u2013. https:\/\/doi.org\/10.1177\/13524585221137697. \u200911.","journal-title":"Mult Scler"},{"issue":"13","key":"4894_CR9","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1177\/1352458519881428","volume":"26","author":"D Jakimovski","year":"2020","unstructured":"Jakimovski D, Zivadinov R, Ramanthan M, Hagemeier J, Weinstock-Guttman B, Tomic D, et al. Serum neurofilament light chain level associations with clinical and cognitive performance in multiple sclerosis: A longitudinal retrospective 5-year study. Mult Scler. 2020;26(13):1670\u201381. https:\/\/doi.org\/10.1177\/1352458519881428.","journal-title":"Mult Scler"},{"issue":"12","key":"4894_CR10","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1177\/13524585221114441","volume":"28","author":"T Williams","year":"2022","unstructured":"Williams T, Tur C, Eshaghi A, Doshi A, Chan D, Binks S, et al. Serum neurofilament light and MRI predictors of cognitive decline in patients with secondary progressive multiple sclerosis: Analysis from the MS-STAT randomised controlled trial. Mult Scler. 2022;28(12):1913\u201326. https:\/\/doi.org\/10.1177\/13524585221114441.","journal-title":"Mult Scler"},{"key":"4894_CR11","doi-asserted-by":"publisher","unstructured":"Aktas O, Renner A, Huss A, Filser M, Baetge S, Stute N, et al. Serum neurofilament light chain: No clear relation to cognition and neuropsychiatric symptoms in stable MS. Neurol Neuroimmunol Neuroinflamm. 2020;7(6). https:\/\/doi.org\/10.1212\/nxi.0000000000000885.","DOI":"10.1212\/nxi.0000000000000885"},{"issue":"11\u201312","key":"4894_CR12","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1177\/13524585241256540","volume":"30","author":"TA Fuchs","year":"2024","unstructured":"Fuchs TA, Schoonheim MM, Zivadinov R, Dwyer MG, Colato E, Weinstock Z, et al. Cognitive progression independent of relapse in multiple sclerosis. Mult Scler. 2024;30(11\u201312):1468\u201378. https:\/\/doi.org\/10.1177\/13524585241256540.","journal-title":"Mult Scler"},{"key":"4894_CR13","doi-asserted-by":"publisher","unstructured":"Ziccardi S, Fuchs T, Guandalini M, Marastoni D, Benedict R. Cognitive Progression Independent of Relapse and MRI Activity in Multiple Sclerosis. Neurology. 2025;1(1). https:\/\/doi.org\/10.1212\/WN9.0000000000000005.https:\/\/doi.org\/https:\/\/.","DOI":"10.1212\/WN9.0000000000000005"},{"issue":"8","key":"4894_CR14","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.3390\/biomedicines13081902","volume":"13","author":"LT Balz","year":"2025","unstructured":"Balz LT, Uttner I, Taranu D, Erhart DK, Fangerau T, Jung S, et al. Sensitivity and Specificity of a Revised Version of the TRACK-MS Screening Battery for Early Detection of Cognitive Impairment in Patients with Multiple Sclerosis. Biomedicines. 2025;13(8):1902. https:\/\/doi.org\/10.3390\/biomedicines13081902.","journal-title":"Biomedicines"},{"issue":"10","key":"4894_CR15","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/s1474-4422(25)00270-4","volume":"24","author":"X Montalban","year":"2025","unstructured":"Montalban X, Lebrun-Fr\u00e9nay C, Oh J, Arrambide G, Moccia M, Pia Amato M, et al. Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria. Lancet Neurol. 2025;24(10):850\u2013. https:\/\/doi.org\/10.1016\/s1474-4422(25)00270-4. \u200965.","journal-title":"Lancet Neurol"},{"issue":"9","key":"4894_CR16","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1001\/jamaneurol.2020.1568","volume":"77","author":"L Kappos","year":"2020","unstructured":"Kappos L, Wolinsky JS, Giovannoni G, Arnold DL, Wang Q, Bernasconi C, et al. Contribution of Relapse-Independent Progression vs Relapse-Associated Worsening to Overall Confirmed Disability Accumulation in Typical Relapsing Multiple Sclerosis in a Pooled Analysis of 2 Randomized Clinical Trials. JAMA Neurol. 2020;77(9):1132\u201340. https:\/\/doi.org\/10.1001\/jamaneurol.2020.1568.","journal-title":"JAMA Neurol"},{"issue":"4","key":"4894_CR17","doi-asserted-by":"publisher","first-page":"2798","DOI":"10.1007\/s00330-021-08329-3","volume":"32","author":"J Kr\u00fcger","year":"2022","unstructured":"Kr\u00fcger J, Ostwaldt AC, Spies L, Geisler B, Schlaefer A, Kitzler HH, et al. Infratentorial lesions in multiple sclerosis patients: intra- and inter-rater variability in comparison to a fully automated segmentation using 3D convolutional neural networks. Eur Radiol. 2022;32(4):2798\u2013809. https:\/\/doi.org\/10.1007\/s00330-021-08329-3.","journal-title":"Eur Radiol"},{"key":"4894_CR18","doi-asserted-by":"publisher","first-page":"102445","DOI":"10.1016\/j.nicl.2020.102445","volume":"28","author":"J Kr\u00fcger","year":"2020","unstructured":"Kr\u00fcger J, Opfer R, Gessert N, Ostwaldt AC, Manogaran P, Kitzler HH, et al. Fully automated longitudinal segmentation of new or enlarged multiple sclerosis lesions using 3D convolutional neural networks. Neuroimage Clin. 2020;28:102445. https:\/\/doi.org\/10.1016\/j.nicl.2020.102445.","journal-title":"Neuroimage Clin"},{"issue":"3","key":"4894_CR19","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1007\/s00330-022-09170-y","volume":"33","author":"R Opfer","year":"2023","unstructured":"Opfer R, Kr\u00fcger J, Spies L, Ostwaldt AC, Kitzler HH, Schippling S, et al. Automatic segmentation of the thalamus using a massively trained 3D convolutional neural network: higher sensitivity for the detection of reduced thalamus volume by improved inter-scanner stability. Eur Radiol. 2023;33(3):1852\u201361. https:\/\/doi.org\/10.1007\/s00330-022-09170-y.","journal-title":"Eur Radiol"},{"issue":"10","key":"4894_CR20","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1007\/s00234-022-02961-6","volume":"64","author":"R Opfer","year":"2022","unstructured":"Opfer R, Kr\u00fcger J, Spies L, Kitzler HH, Schippling S, Buchert R. Single-subject analysis of regional brain volumetric measures can be strongly influenced by the method for head size adjustment. Neuroradiology. 2022;64(10):2001\u20139. https:\/\/doi.org\/10.1007\/s00234-022-02961-6.","journal-title":"Neuroradiology"},{"issue":"9","key":"4894_CR21","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1007\/s11548-024-03201-3","volume":"19","author":"R Opfer","year":"2024","unstructured":"Opfer R, Kr\u00fcger J, Buddenkotte T, Spies L, Behrendt F, Schippling S, et al. BrainLossNet: a fast, accurate and robust method to estimate brain volume loss from longitudinal MRI. Int J Comput Assist Radiol Surg. 2024;19(9):1763\u201371. https:\/\/doi.org\/10.1007\/s11548-024-03201-3.","journal-title":"Int J Comput Assist Radiol Surg"},{"key":"4894_CR22","doi-asserted-by":"publisher","first-page":"109289","DOI":"10.1016\/j.compbiomed.2024.109289","volume":"183","author":"R Opfer","year":"2024","unstructured":"Opfer R, Ziemssen T, Kr\u00fcger J, Buddenkotte T, Spies L, Gocke C, et al. Higher effect sizes for the detection of accelerated brain volume loss and disability progression in multiple sclerosis using deep-learning. Comput Biol Med. 2024;183:109289. https:\/\/doi.org\/10.1016\/j.compbiomed.2024.109289.","journal-title":"Comput Biol Med"},{"key":"4894_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neurobiolaging.2017.12.024","volume":"65","author":"R Opfer","year":"2018","unstructured":"Opfer R, Ostwaldt AC, Sormani MP, Gocke C, Walker-Egger C, Manogaran P, et al. Estimates of age-dependent cutoffs for pathological brain volume loss using SIENA\/FSL-a longitudinal brain volumetry study in healthy adults. Neurobiol Aging. 2018;65:1\u20136. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2017.12.024.","journal-title":"Neurobiol Aging"},{"issue":"8","key":"4894_CR24","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s00415-025-13271-1","volume":"272","author":"S Halbgebauer","year":"2025","unstructured":"Halbgebauer S, Klose V, Fazeli B, Klassen P, Alexudis C, Nagel G, et al. Neurofilament light chain reference values in serum and cerebrospinal fluid: a bi-compartmental analysis in neurological diseases. J Neurol. 2025;272(8):535. https:\/\/doi.org\/10.1007\/s00415-025-13271-1.","journal-title":"J Neurol"},{"key":"4894_CR25","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/hvaf120","author":"S Halbgebauer","year":"2025","unstructured":"Halbgebauer S, Fazeli B, Klose V, Nagel G, Rosenbohm A, Rothenbacher D, et al. Age-Specific Control and Alzheimer Disease Reference Curves and z-Scores for Glial Fibrillary Acidic Protein in Blood. Clin Chem. 2025. https:\/\/doi.org\/10.1093\/clinchem\/hvaf120.","journal-title":"Clin Chem"},{"issue":"2","key":"4894_CR26","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1037\/1040-3590.8.2.145","volume":"8","author":"RH Benedict","year":"1996","unstructured":"Benedict RH, Schretlen D, Groninger L, Dobraski M, Shpritz B. Revision of the Brief Visuospatial Memory Test: Studies of normal performance, reliability, and validity. Psychol Assess. 1996;8(2):145. https:\/\/doi.org\/10.1037\/1040-3590.8.2.145.","journal-title":"Psychol Assess"},{"key":"4894_CR27","volume-title":"Verbaler Lern- und Merkf\u00e4higkeitstest: VLMT: Manual","author":"C Helmstaedter","year":"2001","unstructured":"Helmstaedter C, Lendt M, Lux S. Verbaler Lern- und Merkf\u00e4higkeitstest: VLMT: Manual. 1st ed. Goettingen, Germany: Beltz-Test; 2001.","edition":"1"},{"issue":"5","key":"4894_CR28","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1177\/1352458517690821","volume":"23","author":"RH Benedict","year":"2017","unstructured":"Benedict RH, DeLuca J, Phillips G, LaRocca N, Hudson LD, Rudick R. Validity of the Symbol Digit Modalities Test as a cognition performance outcome measure for multiple sclerosis. Mult Scler. 2017;23(5):721\u201333. https:\/\/doi.org\/10.1177\/1352458517690821.","journal-title":"Mult Scler"},{"issue":"6","key":"4894_CR29","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1177\/1352458511431076","volume":"18","author":"DW Langdon","year":"2012","unstructured":"Langdon DW, Amato MP, Boringa J, Brochet B, Foley F, Fredrikson S, et al. Recommendations for a Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS). Mult Scler. 2012;18(6):891\u20138. https:\/\/doi.org\/10.1177\/1352458511431076.","journal-title":"Mult Scler"},{"key":"4894_CR30","volume-title":"Regensburger Wortfl\u00fcssigkeits-Test (RWT). German ed","author":"S Aschenbrenner","year":"2000","unstructured":"Aschenbrenner S, Tucha O, Lange KW. Regensburger Wortfl\u00fcssigkeits-Test (RWT). German ed. G\u00f6ttingen, Germany: Hogrefe; 2000."},{"issue":"12","key":"4894_CR31","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1177\/1352458509348519","volume":"15","author":"IK Penner","year":"2009","unstructured":"Penner IK, Raselli C, St\u00f6cklin M, Opwis K, Kappos L, Calabrese P. The Fatigue Scale for Motor and Cognitive Functions (FSMC): validation of a new instrument to assess multiple sclerosis-related fatigue. Mult Scler. 2009;15(12):1509\u201317. https:\/\/doi.org\/10.1177\/1352458509348519.","journal-title":"Mult Scler"},{"key":"4894_CR32","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1477-7525-1-29","volume":"1","author":"RP Snaith","year":"2003","unstructured":"Snaith RP, The Hospital Anxiety And Depression Scale. Health Qual Life Outcomes. 2003;1:29. https:\/\/doi.org\/10.1186\/1477-7525-1-29.","journal-title":"Health Qual Life Outcomes"},{"key":"4894_CR33","volume-title":"Statistical Power Analysis for the Behavioral Sciences","author":"J Cohen","year":"1988","unstructured":"Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. Hillsdale, NJ: Lawrence Erlbaum Associates; 1988.","edition":"2"},{"issue":"4","key":"4894_CR34","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1177\/1352458518758911","volume":"25","author":"S Jaeger","year":"2019","unstructured":"Jaeger S, Paul F, Scheel M, Brandt A, Heine J, Pach D, et al. Multiple sclerosis-related fatigue: Altered resting-state functional connectivity of the ventral striatum and dorsolateral prefrontal cortex. Mult Scler. 2019;25(4):554\u2013. https:\/\/doi.org\/10.1177\/1352458518758911. \u200964.","journal-title":"Mult Scler"},{"issue":"9","key":"4894_CR35","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1177\/1352458515614407","volume":"22","author":"MA Rocca","year":"2016","unstructured":"Rocca MA, Meani A, Riccitelli GC, Colombo B, Rodegher M, Falini A, et al. Abnormal adaptation over time of motor network recruitment in multiple sclerosis patients with fatigue. Mult Scler. 2016;22(9):1144\u201353. https:\/\/doi.org\/10.1177\/1352458515614407.","journal-title":"Mult Scler"},{"issue":"13","key":"4894_CR36","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1177\/1352458515625806","volume":"22","author":"E Pravat\u00e0","year":"2016","unstructured":"Pravat\u00e0 E, Zecca C, Sestieri C, Caulo M, Riccitelli GC, Rocca MA, et al. Hyperconnectivity of the dorsolateral prefrontal cortex following mental effort in multiple sclerosis patients with cognitive fatigue. Mult Scler. 2016;22(13):1665\u201375. https:\/\/doi.org\/10.1177\/1352458515625806.","journal-title":"Mult Scler"},{"key":"4894_CR37","doi-asserted-by":"publisher","first-page":"101424","DOI":"10.1016\/j.msard.2019.101424","volume":"36","author":"I H\u00e5kansson","year":"2019","unstructured":"H\u00e5kansson I, Johansson L, Dahle C, Vrethem M, Ernerudh J. Fatigue scores correlate with other self-assessment data, but not with clinical and biomarker parameters, in CIS and RRMS. Mult Scler Relat Disord. 2019;36:101424. https:\/\/doi.org\/10.1016\/j.msard.2019.101424.","journal-title":"Mult Scler Relat Disord"},{"issue":"3","key":"4894_CR38","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1001\/jamaneurol.2022.5250","volume":"80","author":"S Meier","year":"2023","unstructured":"Meier S, Willemse EAJ, Schaedelin S, Oechtering J, Lorscheider J, Melie-Garcia L, et al. Serum Glial Fibrillary Acidic Protein Compared With Neurofilament Light Chain as a Biomarker for Disease Progression in Multiple Sclerosis. JAMA Neurol. 2023;80(3):287\u201397. https:\/\/doi.org\/10.1001\/jamaneurol.2022.5250.","journal-title":"JAMA Neurol"},{"key":"4894_CR39","doi-asserted-by":"publisher","first-page":"623914","DOI":"10.3389\/fneur.2020.623914","volume":"11","author":"M Amin","year":"2020","unstructured":"Amin M, Ontaneda D. Thalamic Injury and Cognition in Multiple Sclerosis. Front Neurol. 2020;11:623914. https:\/\/doi.org\/10.3389\/fneur.2020.623914.","journal-title":"Front Neurol"},{"issue":"4","key":"4894_CR40","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1177\/1352458518760716","volume":"25","author":"KA Koenig","year":"2019","unstructured":"Koenig KA, Rao SM, Lowe MJ, Lin J, Sakaie KE, Stone L, et al. The role of the thalamus and hippocampus in episodic memory performance in patients with multiple sclerosis. Mult Scler. 2019;25(4):574\u2013. https:\/\/doi.org\/10.1177\/1352458518760716. \u200984.","journal-title":"Mult Scler"},{"key":"4894_CR41","doi-asserted-by":"publisher","first-page":"103609","DOI":"10.1016\/j.nicl.2024.103609","volume":"42","author":"R Zivadinov","year":"2024","unstructured":"Zivadinov R, Bergsland N, Jakimovski D, Weinstock-Guttman B, Lorefice L, Schoonheim MM, et al. Thalamic atrophy and dysconnectivity are associated with cognitive impairment in a multi-center, clinical routine, real-word study of people with relapsing-remitting multiple sclerosis. Neuroimage Clin. 2024;42:103609. https:\/\/doi.org\/10.1016\/j.nicl.2024.103609.","journal-title":"Neuroimage Clin"},{"key":"4894_CR42","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.neubiorev.2015.03.008","volume":"54","author":"R Fama","year":"2015","unstructured":"Fama R, Sullivan EV. Thalamic structures and associated cognitive functions: Relations with age and aging. Neurosci Biobehav Rev. 2015;54:29\u201337. https:\/\/doi.org\/10.1016\/j.neubiorev.2015.03.008.","journal-title":"Neurosci Biobehav Rev"},{"issue":"4\u20135","key":"4894_CR43","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/s0010-9452(08)70877-3","volume":"39","author":"YD Van der Werf","year":"2003","unstructured":"Van der Werf YD, Jolles J, Witter MP, Uylings HB. Contributions of thalamic nuclei to declarative memory functioning. Cortex. 2003;39(4\u20135):1047\u201362. https:\/\/doi.org\/10.1016\/s0010-9452(08)70877-3.","journal-title":"Cortex"},{"issue":"3","key":"4894_CR44","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1148\/radiol.2016151809","volume":"280","author":"M Koini","year":"2016","unstructured":"Koini M, Filippi M, Rocca MA, Yousry T, Ciccarelli O, Tedeschi G, et al. Correlates of Executive Functions in Multiple Sclerosis Based on Structural and Functional MR Imaging: Insights from a Multicenter Study. Radiology. 2016;280(3):869\u201379. https:\/\/doi.org\/10.1148\/radiol.2016151809.","journal-title":"Radiology"},{"issue":"14","key":"4894_CR45","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1177\/13524585231201219","volume":"29","author":"SA Morrow","year":"2023","unstructured":"Morrow SA, Weinstock ZL, Mirmosayyeb O, Conway D, Fuchs T, Jaworski MG, et al. Detecting isolated cognitive relapses in persons with MS. Mult Scler. 2023;29(14):1786\u201394. https:\/\/doi.org\/10.1177\/13524585231201219.","journal-title":"Mult Scler"},{"key":"4894_CR46","doi-asserted-by":"publisher","first-page":"100484","DOI":"10.1016\/j.bbih.2022.100484","volume":"24","author":"DS Peres","year":"2022","unstructured":"Peres DS, Rodrigues P, Viero FT, Frare JM, Kudsi SQ, Meira GM, et al. Prevalence of depression and anxiety in the different clinical forms of multiple sclerosis and associations with disability: A systematic review and meta-analysis. Brain Behav Immun Health. 2022;24:100484. https:\/\/doi.org\/10.1016\/j.bbih.2022.100484.","journal-title":"Brain Behav Immun Health"},{"issue":"1","key":"4894_CR47","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1080\/13854046.2023.2192963","volume":"38","author":"M Altieri","year":"2024","unstructured":"Altieri M, Cerciello F, Gallo A, Santangelo G. The relationship between depression and cognitive performance in multiple sclerosis: A meta-analysis. Clin Neuropsychol. 2024;38(1):21\u201341. https:\/\/doi.org\/10.1080\/13854046.2023.2192963.","journal-title":"Clin Neuropsychol"},{"key":"4894_CR48","doi-asserted-by":"publisher","first-page":"106558","DOI":"10.1016\/j.msard.2025.106558","volume":"100","author":"B Kusznir Vitturi","year":"2025","unstructured":"Kusznir Vitturi B. Refining outcome measures in multiple sclerosis clinical trials: A call to action. Mult Scler Relat Disord. 2025;100:106558. https:\/\/doi.org\/10.1016\/j.msard.2025.106558.","journal-title":"Mult Scler Relat Disord"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-026-04894-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-026-04894-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-026-04894-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:17:35Z","timestamp":1781648255000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12883-026-04894-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,17]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4894"],"URL":"https:\/\/doi.org\/10.1186\/s12883-026-04894-6","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,17]]},"assertion":[{"value":"5 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The ethics review committee of the University of Ulm approved this study in accordance with the principles of the Declaration of Helsinki (numbers: 20\/10 on 3rd May 2010; 272\/23 on 22nd September 2023; 335\/23 on 19th December 2023). Written informed consent was obtained from each patient.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The written informed consent form included a statement regarding further processing of the data, e.g., publications.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"DKE received travel grants\/speaker honoraria from Alexion, Merck, Novartis, and argenx (all not related to the topic of the study). RO, LS are employees of jung diagnostics GmbH. LTB, FB, IV, DT, SJ, TF, KK, IU, DL: Nothing to disclose. MS received consulting and\/or speaker honoraria from Alexion, Amgen\/Horizon, Bayer, Biogen, Biotest, Bristol-Myers-Squibb\/Celgene, Janssen, Merck, Roche, Sanofi Genzyme, and UCB (all not related to the topic of the study). HT has participated in meetings sponsored by or received honoraria for acting as an advisor\/speaker for Alexion, Bayer, Biogen, Bristol-Myers Squibb, Celgene, Diamed, Fresenius, Fujirebio, GlaxoSmithKline, Hexal, Horizon, Janssen-Cilag, Merck, Novartis, Roche, Sanofi-Genzyme, Siemens, Teva, and Viatris. He also acknowledges research support by DMSG (German Multiple Sclerosis Society), MWK-BW (Ministry of Science, Research and Arts of the State Baden-W\u00fcrttemberg), BMG (Federal Ministry of Health), University of Ulm, and Chemische Fabrik Karl Bucher (all not related to the topic of the study).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"260"}}